A. Slonim

发表

Nutrition therapy for hepatic glycogen storage diseases.

T. Goldberg, A. Slonim, Teresia Goldberg, 1993, Journal of the American Dietetic Association.

Early Onset of Diabetes Mellitus Associated with the Mitochondrial DNA T14709C Point Mutation: Patient Report and Literature Review

S. Dimauro, F. Santorelli, M. New, 1999, Journal of pediatric endocrinology & metabolism : JPEM.

Effect of Exclusion Diet with Nutraceutical Therapy in Juvenile Crohn's Disease

A. Slonim, M. Grovit, L. Bulone, 2009, Journal of the American College of Nutrition.

Diencephalic syndrome revisited.

I. Butler, A. Slonim, N. Gadoth, 1976, The Journal of pediatrics.

Beneficial effect of diazoxide in obese hyperinsulinemic adults.

R. Alemzadeh, A. Slonim, L. Upchurch, 1998, The Journal of clinical endocrinology and metabolism.

Amino acid disturbances in type III glycogenosis: differences from type I glycogenosis.

R. Coleman, N. Bashan, P. Mushlin, 1983, Metabolism: clinical and experimental.

Multiple serum protein abnormalities in carbohydrate-deficient glycoprotein syndrome: pathognomonic finding of two-dimensional electrophoresis?

M. Harbison, A. Slonim, K. Miller, 1992, Clinical chemistry.

Effect of insulin-like growth factor I in murine muscular dystrophy.

S. Teichberg, M. O'Connor, M. Zdanowicz, 1995, Endocrinology.

Modification of insulin resistance by diazoxide in obese Zucker rats.

M. Zdanowicz, R. Alemzadeh, A. Slonim, 1993, Endocrinology.

Insulin-Like Growth Factor-I and High Protein Diet Decrease Calpain-Mediated Proteolysis in Murine Muscular Dystrophy

M. Zdanowicz, A. Slonim, M. Wingertzahn, 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Metabolic and Structural Effects of Insulin-like Growth Factor-I and High-Protein Diet on Dystrophic Hamster Skeletal Muscle

S. Teichberg, M. O'Connor, M. Zdanowicz, 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy.

R. Coleman, A. Slonim, W. S. Moses, 1984, The Journal of pediatrics.

Recent Advances in Treatment of the Glycogenoses

A. Slonim, 1985 .

The role of dietary zinc in modifying the onset and severity of spontaneous diabetes in the BB Wistar rat.

R. Wapnir, M. Zdanowicz, A. Slonim, 1998, Molecular genetics and metabolism.

Protection against streptozotocin-induced diabetes by superoxide dismutase

A. Slonim, M. J. Robbins, I. Burr, 2005, Diabetologia.

Effect of Streptozotocin on Red-blood-cell-reduced Glutathione: Modification by Glucose, Nicotinamide, and Epinephrine

A. Slonim, I. Burr, T. Fletcher, 1976, Diabetes.

Elevated cholesterol and bile acid synthesis in an adult patient with homozygous familial hypercholesterolemia. Reduction by a high glucose diet.

S. Grundy, H. Greene, P. Stacpoole, 1981, The Journal of clinical investigation.

High protein diet has beneficial effects in murine muscular dystrophy.

S. Teichberg, M. O'Connor, M. Zdanowicz, 1995, The Journal of nutrition.

Hyperprolactinemia associated with advanced puberty in a male.

A. Glick, A. Slonim, D. Island, 1982, The Journal of pediatrics.

Nonketotic hypoglycemia

R. Mrak, P. Borum, A. Slonim, 1983, Neurology.

Correction of glycogen storage disease type II by enzyme replacement with a recombinant human acid maltase produced by over-expression in a CHO-DHFR(neg) cell line.

W. Rom, N. Raben, F. Martiniuk, 2000, Biochemical and biophysical research communications.

Improvement of muscle function in acid maltase deficiency by high‐protein therapy

K. Hirschhorn, R. Coleman, R. Mrak, 1983, Neurology.

Two Cases of Pulmonary Hypertension Associated with Type III Glycogen Storage Disease.

W. Chung, Teresa M. Lee, A. Slonim, 2011, JIMD reports.

Neuromuscular Involvement in Glycogen Storage Disease Type III

N. Gadoth, N. Bashan, A. Slonim, 1986, Acta paediatrica Scandinavica.

Reversal of debrancher deficiency myopathy by the use of high‐protein nutrition

O. B. Evans, P. Benke, A. Slonim, 1982, Annals of neurology.

Modification of the natural history of adult‐onset acid maltase deficiency by nutrition and exercise therapy

J. Galanko, F. Martiniuk, T. Goldberg, 2007, Muscle & nerve.

Modification of chemically induced diabetes in rats by vitamin E. Supplementation minimizes and depletion enhances development of diabetes.

A. Slonim, I. Burr, R. Sharp, 1983, The Journal of clinical investigation.

Helios gene gun particle delivery for therapy of acid maltase deficiency.

W. Rom, N. Raben, F. Martiniuk, 2002, DNA and cell biology.

Identification of two subtypes of infantile acid maltase deficiency.

F. Martiniuk, T. Goldberg, A. Slonim, 2000, The Journal of pediatrics.

Necessity of complete intake of phenylalanine-free amino acid mixture for metabolic control of phenylketonuria.

F. Rohr, H. Levy, A. Slonim, 1999, Journal of the American Dietetic Association.

Biotinidase deficiency: Novel mutations and their biochemical and clinical correlates

D. Goudie, M. Blitzer, Helio F. Pedro, 2005, Human mutation.

Nocturnal intragastric therapy in type I glycogen storage disease: effect on hormonal and amino acid metabolism.

H. Greene, W. Lacy, A. Slonim, 1979, Metabolism: clinical and experimental.

Benign course of glycogen storage disease type IIb in two brothers: Nature or nurture?

S. Dimauro, S. Tsujino, A. Hays, 2006, Muscle & nerve.

Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.

H. Greene, A. Slonim, J. O'Neill, 1976, The New England journal of medicine.

Chemiluminescence as an Index of Drug-induced Free Radical Production in Pancreatic Islets

K. Asayama, D. English, A. Slonim, 1984, Diabetes.

Evaluation of the lumbar spine in patients with glycogen storage disease: CT demonstration of patterns of paraspinal muscle atrophy.

M. Gorey, K. Black, A. Slonim, 1991, AJNR. American journal of neuroradiology.

Clinical response of alopecia, trichorrhexis nodosa, and dry, scaly skin to zinc supplementation.

N. Sadick, A. Slonim, C. Meyers-Seifer, 1992, The Journal of pediatrics.

The effects of high sodium chloride in the growth medium on the content of the essential amino acids in the intracellular pool in Baker's yeast during aerobic fermentation of glucose

R. D. Tanner, A. Slonim, G. Malaney, 1989 .

True hermaphroditism : A rational approach to diagnosis and treatment

J. Warner, J. Warner, R. Rhamy, 1980 .

Nutritional Management of Short Bowel Syndrome in the Adult with Crohn’s Disease

Kathie G. Ferbas, A. Slonim, M. Grovit, 2014 .

Dietary-dependent carnitine deficiency as a cause of nonketotic hypoglycemia in an infant.

C. Stanley, H. Greene, P. Borum, 1981, The Journal of pediatrics.

Epimerase-deficiency galactosemia is not a binary condition.

M. Epstein, J. Fridovich-Keil, F. Scaglia, 2006, American journal of human genetics.

Novel mutation in the mitochondrial DNA tRNA glycine gene associated with sudden unexpected death.

S. Dimauro, F. Santorelli, A. Slonim, 1996, Pediatric neurology.

Myopathy in McArdle's syndrome. Improvement with a high-protein diet.

A. Slonim, P. J. Goans, 1985, The New England journal of medicine.

Pompe disease diagnosis and management guideline

David M. Rapoport, Michael S. Watson, Robert D. Steiner, 2006, Genetics in Medicine.

A preliminary study of growth hormone therapy for Crohn's disease.

M. Mckinley, T. Goldberg, A E Slonim, 2000, The New England journal of medicine.

ATP depletion, a possible role in the pathogenesis of hyperuricemia in glycogen storage disease type I.

H. Greene, T. Claus, J. Moran, 1978, The Journal of clinical investigation.

Type I glycogen storage disease: five years of management with nocturnal intragastric feeding.

H. Greene, J. Moran, A. Slonim, 1980, The Journal of pediatrics.

Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy.

H. Greene, F. Ghishan, A. Slonim, 1981, Gastroenterology.

Familial cerebellar ataxia with muscle coenzyme Q10 deficiency

S. Dimauro, B. Weissman, J. Mendell, 2001, Neurology.

Pompe disease diagnosis and management guideline ACMG Work Group on Management of Pompe Disease :

B. Byrne, D. Rapoport, M. Watson, 2006 .

Type I glycogen storage disease: a metabolic basis for advances in treatment.

H. Greene, A. Slonim, I. Burr, 1979, Advances in pediatrics.

894 DIFFERING FOOD COMPOSITION FOR NOCTURNAL INTRAGASTRIC THERAPY IN TYPES I AND III GLYCOGEN STORAGE DISEASE (GSD)

H. Greene, P. Benke, A. Slonim, 1978, Pediatric Research.

Metabolic and clinical response to recombinant human insulin-like growth factor I in myotonic dystrophy--a clinical research center study.

D. Matthews, J. Zachwieja, D. Bier, 1995, The Journal of clinical endocrinology and metabolism.

Extracellular calcium and adrenergic and cholinergic effects on islet beta-cell function.

A. Slonim, I. Burr, T. Fletcher, 1976, The American journal of physiology.

Erratum: Pompe disease diagnosis and management guidelines (Genetics in Medicine (May 2006) 8 (267-288))

B. Byrne, D. Rapoport, M. Watson, 2006 .

Induction of spermatogenesis in hypogonadotrophic hypogonadism.

J. Steiner, A. Slonim, I. Spitz, 1978, Postgraduate medical journal.

Role of D-tryptophan oxidase in D-tryptophan utilization by Escherichia coli

R. Hadar, J. Kuhn, A. Slonim, 1976, Journal of bacteriology.

MUTATION IN BRIEF

Sharon Quary, A. Slonim, T. Baykal, 2022 .